GT-20029

N/A

Report date: 2024/07/09 17:58:43
NME

Base Information

Drug NameGT-20029
Drug Alias NameGT-20029
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionAndrogen Receptor degraders
TargetsAndrogen Receptor
Therapy Area/IndicationsAlopeciaAcne Vulgaris
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSuzhou Koshine Biomedica Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesSuzhou Koshine Biomedica Inc
Inactive CompaniesN/A
Active IndicationsAlopeciaAcne Vulgaris
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A